Cooper Ronald Harold Wilfred
Insider CIK 1676880 · ALBO President and CEO, Director · GNCA Director · CCCC Director · GBIO Director · ENGN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 62,000 | — | $0 | 62,000 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 2,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 6,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,920 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 950 | — | $0 | 0 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 801,000 | — | $0 | 801,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 35,500 | — | $0 | 35,500 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2025-06-04 | 2025-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2025-01-29 | 2025-01-31 | 850,000 | — | $0 | 850,000 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-09-27 | 2024-10-01 | 10,000 | $5.70 | $57.0K | 10,000 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2024-07-22 | 2024-07-24 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 65,000 | — | $0 | 65,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2024-06-06 | 2024-06-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 123,750 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 132,150 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 219,350 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 155,381 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 19,422 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 60,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 124,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 124,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 93,000 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 43,027 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | U Tender | 2023-03-02 | 2023-03-02 | 33,094 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-23 | 2023-01-23 | 1,057 | $43.80 | $46.3K | 57,444 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-25 | 195,000 | — | $0 | 252,444 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-27 | 195,000 | — | $0 | 252,444 | SEC↗ |
| GBIO Generation Bio Co. | A Award | 2023-01-05 | 2023-01-09 | 9,500 | $5.12 | $48.6K | 9,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2023-01-09 | 919 | $19.58 | $18.0K | 58,501 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 919 | $19.58 | $18.0K | 55,461 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 929 | $24.67 | $22.9K | 56,380 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2022-06-09 | 2022-06-13 | 19,200 | — | $0 | 19,200 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 907 | $33.11 | $30.0K | 56,082 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 3,684 | $24.88 | $91.7K | 56,989 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2022-01-18 | 2022-01-20 | 132,150 | — | $0 | 132,150 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2021-09-17 | 2021-09-20 | 11,973 | — | $0 | 43,027 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2021-09-17 | 2021-09-20 | 11,973 | $19.19 | $229.8K | 68,433 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | F Tax w/h | 2021-09-17 | 2021-09-20 | 7,760 | $29.61 | $229.8K | 60,673 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2021-03-01 | 2021-03-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 93,000 | — | $0 | 93,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 48,700 | — | $0 | 56,460 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 124,000 | — | $0 | 124,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 124,000 | — | $0 | 124,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | P Buy | 2018-11-13 | 2018-11-15 | 1,026 | $25.02 | $25.7K | 7,760 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | P Buy | 2018-08-14 | 2018-08-16 | 588 | $31.63 | $18.6K | 6,534 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | P Buy | 2018-08-14 | 2018-08-16 | 200 | $32.50 | $6.5K | 6,734 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 123,750 | — | $0 | 123,750 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-08-21 | 2017-08-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2017-06-13 | 2017-06-15 | 15,000 | $5.34 | $80.1K | 15,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-01-20 | 2017-01-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2016-11-03 | 2016-11-07 | 19,422 | — | $0 | 19,422 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2016-11-03 | 2016-11-07 | 155,381 | — | $0 | 155,381 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2016-11-03 | 2016-11-07 | 5,946 | — | $0 | 5,946 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2016-06-07 | 2016-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |